A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients

Clinical trial NCT03821272 · COMPLETED

Trial details

NCT number: NCT03821272
Sponsor: University of Arkansas
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2019-11-13
Primary completion: 2025-02-03
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.